Research & Development



  送走了若有所悟的郭解,雲瑯嘆口氣對窗戶外面道︰“您就進來吧,外面冷!”   經過連續不斷的擴建,長門宮主樓,變成了上林苑里面最龐大的一座建築,即便是甘泉宮在長門宮面前也相形見絀。超碰在线视频Ca0P0rn97   如果掐頭去尾的算,雲瑯至少看過上億的字。超碰免费公开视频   一般來說,剝奪別人的生命就是最殘酷的手段,那些聰明的掌權者們,唯恐其余人不能接受教育,結束模仿那個罪人的行為,不能產生足夠多的物傷其類的奇妙感覺,就盡量的讓那個罪人在臨死前遭受最恐怖的懲罰。   雲瑯當然知道這種心理的存在,因此,為了拔高這種錯覺,他今天穿的非常華麗。超碰97资源站   雲瑯正色道︰“我們不是一伙的,我出自西北理工,我的山門雖然已經毀掉了,也不容人隨意攀誣。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo